Histological regression of giant cell tumor of bone following RANK ligand inhibition

Martin F. Dietrich, Dominick C Cavuoti, Michael J Landay, Yull E Arriaga

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Lung metastases are a rare complication of giant cell tumors of bone. We herein describe an interesting case of histological regression and size reduction of lung metastases originating from a primary giant cell tumor of bone in response to the RANK ligand inhibitor denosumab.

Original languageEnglish (US)
JournalJournal of Investigative Medicine High Impact Case Reports
Volume2
Issue number4
DOIs
StatePublished - Jan 1 2014

Keywords

  • Denosumab
  • Giant cell tumor
  • Lung metastases
  • RANK ligand

ASJC Scopus subject areas

  • Epidemiology
  • Safety, Risk, Reliability and Quality
  • Safety Research

Fingerprint Dive into the research topics of 'Histological regression of giant cell tumor of bone following RANK ligand inhibition'. Together they form a unique fingerprint.

  • Cite this